Anti-EIF2B1 Antibody

$99.00$319.00

Reactivity: Human
Applications: ELISA,IHC
Conjugation: Various
Supplier: CUSABIO BIOTECH CO.

Clear
-$50 as credit for submitting review for primary antibody
Shipping notice:
Product will be delivered in 6 to 8 Business Days

Rabbit Anti-EIF2B1 Antibody (CSB-PA623910ESR1HU)

Supplier: CUSABIO BIOTECH CO.

Alternative names:

Translation initiation factor eIF-2B subunit alpha Antibody,eIF-2B GDP-GTP exchange factor subunit alpha Antibody,EIF2B1 Antibody,EIF2BA Antibody

More alternative names for the antibody
EI2BA_HUMAN antibody|eIF-2B GDP-GTP exchange factor subunit alpha antibody|EIF2B antibody|Eif2b1 antibody|EIF2BA antibody|Eukaryotic translation initiation factor 2B subunit 1 alpha 26kDa antibody|Translation initiation factor eIF-2B subunit alpha antibody
Anti-EIF2B1 antibody (ab170662)
Close sc-376846|sc-79936|sc-98323|

Recommended applications: ELISA, IHC

Recommended dilution: Recommended dilution:IHC:1:20-1:200

Recommended protocols: check protocols

Name

Anti-EIF2B1 Antibody

Catalogue No.

CSB-PA623910ESR1HU

Reactivity

Human

Immunogen

Recombinant human Translation initiation factor eIF-2B subunit alpha protein (1-305AA)

Host

Rabbit

Applications

ELISA, IHC

Recommended dilution

Recommended dilution:IHC:1:20-1:200

Clonality

Polyclonal

Conjugation

unconjugated

Isotype

IgG

Molecular weight

33 kDa

Purification

Antigen Affinity Purified

Storage

Shipped at 4 Celcius Degree. Upon delivery aliquot and store at -20 Celcius Degree or -80 Celcius Degree. Avoid repeated freeze.

Database links

Entrez Gene:1967( Human), Omim:606686( Human), SwissProt:Q14232( Human), Unigene:741273( Human)

Protein function

Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP.

Involvement in disease

Leukodystrophy with vanishing white matter (VWM) [MIM:603896]: A leukodystrophy that occurs mainly in children. Neurological signs include progressive cerebellar ataxia, spasticity, inconstant optic atrophy and relatively preserved mental abilities. The disease is chronic-progressive with, in most individuals, additional episodes of rapid deterioration following febrile infections or minor head trauma. While childhood onset is the most common form of the disorder, some severe forms are apparent at birth. A severe, early-onset form seen among the Cree and Chippewayan populations of Quebec and Manitoba is called Cree leukoencephalopathy. Milder forms may not become evident until adolescence or adulthood. Some females with milder forms of the disease who survive to adolescence exhibit ovarian dysfunction. This variant of the disorder is called ovarioleukodystrophy. . Note=The disease is caused by mutations affecting the gene represented in this entry.

Protein sequence and domain

Belongs to the eIF-2B alpha/beta/delta subunits family.

Research area

All research areas>Signaling Intermediates>eIF
(View all antibody categories related to Signaling Intermediates)

Note

AntibodyPlus provides antibody trial sample for your own antibody validation and collects antibody reviews.

Supplier

CUSABIO BIOTECH CO.

Product type

Primary antibody

Reviews


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review

There are no reviews for this product yet.
By submitting a review, get following benefits:

1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!

view database submit reviews

There is no extra validation for this product yet.
Check other extra validated antibodies below:



Welcome to AntibodyPlus!